Details for: EXJADE
Company: NOVARTIS PHARMACEUTICALS CANADA INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02287420 | EXJADE | DEFERASIROX | 125 MG | TABLET FOR SUSPENSION | ORAL |
| 02287439 | EXJADE | DEFERASIROX | 250 MG | TABLET FOR SUSPENSION | ORAL |
| 02287447 | EXJADE | DEFERASIROX | 500 MG | TABLET FOR SUSPENSION | ORAL |
Summary Reports
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.